Upregulation of components of the IFN-γ signaling in the circulation may therefore be an indicator of an active immune system, which is required to kill cancer cells and to inhibit tumor growth through responses elicited by its innate and adaptive arms [77]. This evidence concerns the gene IFNG and cancer.